Ring-shaped device

US9486362B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9486362-B2
Application numberUS-200913146614-A
CountryUS
Kind codeB2
Filing dateDec 25, 2009
Priority dateFeb 10, 2009
Publication dateNov 8, 2016
Grant dateNov 8, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention aims to provide a ring-shaped device superior in the wearing comfort and intraocular stability while being worn on the eye. Provided is a ring-shaped device to be worn on the scleral surface, which is characterized in that it has an opening to expose the cornea and an intermediate portion between an inner edge portion and an outer edge portion has a maximum thickness.

First claim

Opening claim text (preview).

The invention claimed is: 1. A device to be worn on a scleral surface, wherein the device is made of a curved thin film having a ring shape, and the device has an opening to expose a cornea, wherein one surface of the curved thin film forms a concave surface and another surface of the curved thin film forms a convex surface, and the concave surface and the convex surface have different curvatures, wherein the curved thin film has an intermediate portion between an inner edge portion and an outer edge portion, wherein the intermediate portion has a minimum thickness and a maximum thickness, and wherein the inner edge portion has a thickness within the range of 0.05-0.3 mm, the outer edge portion has a thickness within the range of 0.05-0.3 mm, the intermediate portion has a thickness within the range of 0.08-0.4 mm, the minimum thickness of the intermediate portion is not less than the thickness of the inner edge portion and is not less than the thickness of the outer edge portion, and the maximum thickness of the intermediate portion is greater by 0.03 mm or more than both the thickness of the inner edge portion and the thickness of the outer edge portion. 2. The device according to claim 1 , wherein the inner edge portion has a thickness within the range of 0.1-0.3 mm, the outer edge portion has a thickness within the range of 0.15-0.3 mm, and the intermediate portion has a thickness within the range of 0.2-0.4 mm. 3. A device comprising a drug, wherein the device is to be worn on a scleral surface, wherein the device is made of a curved thin film having a ring shape, and the device has an opening to expose a cornea, wherein one surface of the curved thin film forms a concave surface and another surface of the curved thin film forms a convex surface, and the concave surface and the convex surface have different curvatures, wherein the curved thin film has an intermediate portion between an inner edge portion and an outer edge portion, wherein the intermediate portion has a maximum thickness, wherein the inner edge portion has a thickness within the range of 0.05-0.3 mm, the outer edge portion has a thickness within the range of 0.05-0.3 mm, the intermediate portion has a thickness within the range of 0.08-0.4 mm, the minimum thickness of the intermediate portion is not less than the thickness of the inner edge portion and is not less than the thickness of the outer edge portion, and the maximum thickness of the intermediate portion is greater by 0.03 mm or more than both the thickness of the inner edge portion and the thickness of the outer edge portion, and wherein the curved thin film is impregnated with the drug. 4. The device according to claim 3 , wherein the inner edge portion has a thickness within the range of 0.1-0.3 mm, the outer edge portion has a thickness within the range of 0.15-0.3 mm, and the intermediate portion has a thickness within the range of 0.2-0.4 mm. 5. A method of delivering a drug to posterior ocular tissues, comprising applying the device according to claim 3 on the scleral surface to transfer the drug contained in the device to posterior ocular tissues. 6. The device according to claim 3 , wherein the drug is a therapeutic agent for a posterior ocular tissue disease.

Assignees

Inventors

Classifications

  • ortho- or peri-condensed with heterocyclic ring systems · CPC title

  • A61F9/0017Primary

    implantable in, or in contact with, the eye, e.g. ocular inserts · CPC title

  • A61F9/04Primary

    Eye-masks {; Devices to be worn on the face, not intended for looking through; Eye-pads for sunbathing} · CPC title

  • Devices for applying media, e.g. remedies, on the human body (devices for handling toiletry or cosmetic substances A45D; absorbent pads, e.g. swabs, A61F13/15) · CPC title

  • Contact lenses for the eyes (disinfection or sterilisation of contact lenses A61L12/00) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9486362B2 cover?
The present invention aims to provide a ring-shaped device superior in the wearing comfort and intraocular stability while being worn on the eye. Provided is a ring-shaped device to be worn on the scleral surface, which is characterized in that it has an opening to expose the cornea and an intermediate portion between an inner edge portion and an outer edge portion has a maximum thickness.
Who is the assignee on this patent?
Shikamura Yuko, Sato Takao, Matsunaga Toru, and 4 more
What technology area does this patent fall under?
Primary CPC classification A61F9/0017. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).